Nobutada Tanaka

10PUBLICATIONS
26CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesPharmacogenomicsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 06, 2026
Reverse Fosmidomycin Analogs as Bisubstrate Inhibitors: Binding Mode Elucidation and Mechanistic Insights.

|Jan 15, 2025
Expanding the Chemical Space of Reverse Fosmidomycin Analogs.

Talea Knak, Sana Takada, Boris Illarionov

|Jan 11, 2025
The Diverse Binding Modes Explain the Nanomolar Levels of Inhibitory Activities Against 1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase from Plasmodium falciparum Exhibited by Reverse Hydroxamate Analogs of Fosmidomycin with Varying N-Substituents.

Sana Takada, Mona A Abdullaziz, Stefan Höfmann

|Apr 22, 2024
Reverse N-Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase (DXR).

Mona A Abdullaziz, Sana Takada, Boris Illarionov

|Jun 14, 2023
Design and Pharmacological Chaperone Effects of N-(4'-Phenylbutyl)-DAB Derivatives Targeting the Lipophilic Pocket of Lysosomal Acid α-Glucosidase.

Atsushi Kato, Izumi Nakagome, Maki Kise

|Dec 23, 2022
Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities.

Talea Knak, Mona A Abdullaziz, Stefan Höfmann

Pageof 2

Frequent Collaborators

5 joint publications

Stefan Höfmann

5 joint publications

Thomas Kurz

4 joint publications

Yasumitsu Sakamoto

4 joint publications

Sana Takada